Magellan Diagnostics, Inc. Expands Voluntary Recall of LeadCare® Test Kits
Murilo Freitas - 04:00, 1 de septiembre de 2021458
0
Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced its wholly owned subsidiary, Magellan Diagnostics, Inc. (“Magellan”), expanded the Class I recall of its LeadCare® II Blood Lead Test Kits, LeadCare Plus® Blood Lead T